COMT and Parkinson disease: In summary, in PD patients treated with LCIG, addition of a COMT inhibitor (oral or LECIG) may be considered if a reduction of levodopa consumption is needed, but these patients require close monitoring in an inpatient setting during the dose adjustment period.